Novavax Inc (NVAX)

[LongRun8]

Another nice day with increasing share price on good volume. Four green days in a row. I emailed IR and they never said they were going to release interim data results, so it looks like we might have to wait until the trial is over to get the data on RSV vaccine in pregnant women. Hopefully the share price keeps going up nicely until then. The pop that people want in NVAX share price (assuming positive Ph2 data) will depend on the price action leading up to the data release. If the share price already has increased significantly, we might experience less of a jump on positive news; but I'm sure we'll still get a nice bump. The potential is too great.